
Physician-reviewed TRT education
Testosterone cypionate is a long-acting injectable testosterone ester commonly used to treat appropriately diagnosed male hypogonadism. Dose and frequency should be individualized from symptoms, laboratory results, response and adverse effects.
Medically reviewed by Dr. Timothy Mackey
Medical Director · Updated September 2026

Testosterone cypionate is an FDA-approved injectable testosterone product for replacement therapy in males with certain conditions associated with deficient or absent endogenous testosterone. It is an ester of testosterone formulated for intramuscular administration in its FDA-approved labeling.
It should not be prescribed simply because a man wants a higher testosterone number. Proper TRT begins with compatible symptoms and appropriately confirmed low testosterone, followed by evaluation of the cause and individualized monitoring.
Testosterone cypionate is testosterone attached to the cypionate ester, which slows release after injection. Once released and metabolized, the active hormone is testosterone. The ester primarily changes pharmacokinetics; it does not make the testosterone molecule inherently more “natural” or more “bioidentical” than other testosterone preparations.
For a broader overview, see our testosterone replacement therapy guide.
FDA labeling includes replacement therapy in males with primary hypogonadism and hypogonadotropic hypogonadism caused by specified congenital or acquired conditions. A clinician should establish the diagnosis before treatment and investigate potentially reversible causes when appropriate.
Age-related symptoms alone do not establish hypogonadism. Testosterone testing, symptoms, medications, sleep, weight, pituitary/testicular function and other health factors may all be relevant.
The FDA-approved product labeling describes deep intramuscular injection. In clinical practice, route and dosing strategy may vary depending on the prescribed product and clinician judgment. Patients should follow the route printed on their prescription and the technique demonstrated by their healthcare team.
See our testosterone injection safety guide for sterile technique, supplies and sharps disposal.
There is no single schedule that is ideal for every patient. FDA labeling permits dosing intervals that differ from many contemporary TRT practices, while clinicians may use smaller, more frequent doses to manage symptoms, peaks, troughs and adverse effects. The correct regimen depends on the individual patient and achieved testosterone concentrations.
Patients should not copy another person's weekly dose or change frequency without discussing it with the prescriber. See our guide to testosterone dosing.
Testosterone cypionate and testosterone enanthate are both long-acting injectable esters used for testosterone replacement. Their pharmacokinetic differences are relatively modest, and one is not universally “better.” Availability, formulation, carrier oil, tolerability, dosing strategy and patient response can influence the choice.
Read the detailed comparison: testosterone cypionate vs. enanthate.
In appropriately diagnosed men, testosterone replacement can improve symptoms related to androgen deficiency. Potential benefits may involve sexual symptoms, body composition, anemia, bone density or other domains depending on the patient's baseline condition. Response varies, and treatment should be continued because benefits outweigh risks for that individual—not merely to chase a laboratory target.
Potential adverse effects include acne or oily skin, edema, gynecomastia, changes in mood or libido, suppression of sperm production, testicular atrophy and increased hemoglobin/hematocrit. Injection-site reactions can also occur.
Testosterone products carry labeling related to blood pressure and other risks, and treatment requires individualized assessment. Patients should promptly report concerning symptoms and attend scheduled monitoring.
Injectable testosterone can raise hemoglobin and hematocrit. The AUA recommends baseline measurement and intervention when hematocrit reaches 54% or higher during therapy. Persistently elevated hematocrit should trigger review of testosterone exposure and other causes rather than automatic indefinite blood donation.
Read our detailed guide to high hematocrit on TRT.
Exogenous testosterone suppresses LH and FSH and can substantially reduce sperm production. Men who want current or future fertility should discuss this before starting TRT. Testosterone monotherapy is generally inappropriate when near-term conception is a goal.
See our TRT and fertility guide and information about hCG therapy.
Monitoring commonly includes symptoms, testosterone concentrations, CBC/hematocrit and other testing based on age, medical history, formulation and risk factors. PSA/prostate assessment may be appropriate for selected men. The goal is to confirm benefit, identify adverse effects and adjust treatment when necessary.
It is an androgen and anabolic steroid medication, but medically prescribed testosterone replacement is different from nonmedical anabolic-steroid use. The clinical objective is replacement in appropriately diagnosed deficiency.
After the ester is cleaved, the active hormone is testosterone. “Bioidentical” is not a marker of FDA approval, safety or product quality, and the term should not be used to imply that one ester is inherently safer than another.
It is a long-acting ester with effects that persist beyond the day of injection. Exact pharmacokinetics vary by dose, formulation and individual physiology, so dosing should be guided clinically rather than by a single internet half-life number.
It can suppress sperm production, sometimes severely. Fertility goals should be discussed before treatment, and men actively trying to conceive generally need a different strategy.
Some clinicians use subcutaneous testosterone regimens, but the FDA-approved labeling for standard testosterone cypionate injection specifies intramuscular use. Follow the route prescribed for your exact product.
NovaGenix can review symptoms, repeat testosterone testing, medical history, fertility goals and treatment options before determining whether TRT is appropriate. Learn more about Dr. Timothy Mackey and NovaGenix Health & Wellness.
Call 561-277-8260 | Text NovaGenix | Schedule a Consultation
This article is educational and does not replace individualized medical advice, diagnosis or prescription instructions.
Speak with NovaGenix about physician-led evaluation, testing, and treatment options in Jupiter, Florida.
Medical disclaimer: This article is for general educational purposes only and is not medical advice, a diagnosis, or a treatment recommendation. Reading it does not create a physician-patient relationship. Always consult a qualified healthcare professional about your individual circumstances, and never delay seeking care because of something you read here. If you are experiencing a medical emergency, call 911. Read our full Medical Disclaimer.


609 N Hepburn avenue suite 106. Jupiter, Florida 33458
609 N Hepburn avenue suite 106. Jupiter, Florida 33458
561-277-8260
Learn what you want to know about hormone therapy by scheduling a free consultation.
Contact Us Today609 N Hepburn Ave Ste 106, Jupiter, FL 33458
Monday - Friday: 9:00 am - 5:00 pm | Saturday-Sunday: Closed